The cutthroat battle for the US weight-loss drug market
Weight-loss drug prices are falling in the US - but can the example be repeated?
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"What it does is highlight some of the lack of transparency."
— Alison Sexton Ward , Academic
Key People
Locations
Tags
All Coverage
Weight-loss drug prices are falling in the US - but can the example be repeated?
Similar Stories
Related coverage based on topic and tags
Novo CEO says obesity market won't be winner-take-all battle with Lilly - reuters.com
Novo CEO says obesity market won't be winner-take-all battle with Lilly reuters.com
August 13, 2026 at 10:02 AMNew weight-loss pill approved for use in UK
Foundayo is made by Eli Lilly, the drug firm behind the Mounjaro jab.
August 10, 2026 at 03:25 PMLilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide - reuters.com
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide reuters.com
August 12, 2026 at 10:27 AMNovo begins study to find lowest effective dose for Wegovy pill - Reuters
Novo begins study to find lowest effective dose for Wegovy pill Reuters
August 19, 2026 at 03:26 PMNovartis defeats UK court bid to invalidate blockbuster drug Entresto patent - Reuters
Novartis defeats UK court bid to invalidate blockbuster drug Entresto patent Reuters
August 13, 2026 at 09:31 PMInside Health
Plus, how much do people really change their habits for a free coffee?
August 11, 2026 at 09:00 AM